CAF-C7 engages in complex crosstalk with the tumor epithelial and endothelial interface through the IGF1-IGF1R signaling axis, thereby promoting anoikis resistance, enhancing metastatic potential, and facilitating angiogenesis. The gene discussed is IGF1R; the disease is neoplasm.